Skip to main content
animation of illustrated demodex mites holding party favors in front of an illustrated eye
animation of illustrated demodex mites holding party favors in front of an illustrated eye
animation of illustrated demodex mites holding party favors in front of an illustrated eye

Is There aMite Party on Your Eyelids?

If you're experiencing eyelid itching or crusties (collarettes), you're not alone.1-3

XDEMVY® can help break up mite parties by targeting and killing the Demodex mites that cause Demodex blepharitis (DB).4,5 If you are unsure about whether you have DB, answer a few questions to uncover its impact on you.

Take Quiz Now See how XDEMVY works

animation of illustrated demodex mites holding party favors in front of an illustrated eye

Is There aMite Party on Your Eyelids?

If you're experiencing eyelid itching or crusties (collarettes), you're not alone.1-3

XDEMVY® can help break up mite parties by targeting and killing the Demodex mites that cause Demodex blepharitis (DB).4,5 If you are unsure about whether you have DB, answer a few questions to uncover its impact on you.

Take Quiz Now See how XDEMVY works

“What causes Demodex blepharitis (DB)?” “How does XDEMVY work?” “What should I expect after my prescription is sent to the pharmacy?” “Are there any downloadable resources available?” “Where can I find a DB specialist?”

See XDEMVY in Action

With a simple swipe, view the impact of XDEMVY treatment on eyelids with DB.

View BEFORE and AFTER photos from actual patients by selecting below.

image of before and after treatment with xdemvy
image of before and after treatment with xdemvy

BEFORE

AFTER

Select a patient, then click, hold, and slide to witness the results of XDEMVY.

Select a patient, then slide to witness the results of XDEMVY.

PATIENT 1 PATIENT 2 PATIENT 3

Real patient with DB used XDEMVY twice daily, in each eye, for 6 weeks. Results may vary.

SEE MORE RESULTS

Party's over

Party's Over With XDEMVY

IT’S NOT YOU—IT’S DEMODEX MITES

If mites are having a party on your eyelids, it’s time to eliminate the root of the problem.4 Watch this video now.

Dr Iravani

Dr Iravani

TREATING DB WITH XDEMVY

Dr Iravani discusses the process of diagnosing DB and the ability to treat it with XDEMVY.

Illustrated demodex mite standing next to upright clipboard

XDEMVY DISCUSSION GUIDE

Answer a few questions to prepare to talk to your eye
doctor about whether XDEMVY can help you.

FILL OUT NOW
map pin icon next to stunned demodex mite

DB doctors near you

Locate DB-knowledgeable eye  doctors in your area.

Find an eye doctor
demodex mite saying oh no with text that reads party’s over
References

References: 1. Fromstein SR, Harthan JS, Patel J, Opitz DL. Demodex blepharitis: clinical perspectives. Clin Optom (Auckl). 2018;10:57-63. 2. Trattler W, Karpecki P, Rapoport Y, et al. The prevalence of Demodex blepharitis in US eye care clinic patients as determined by collarettes: a pathognomonic sign. Clin Ophthalmol. 2022;16:1153-1164. 3. Sędzikowska A, Osęka M, Grytner-Zięcina B. Ocular symptoms reported by patients infested with Demodex mites. Acta Parasitol. 2016;61(4):808-814. 4. XDEMVY. Prescribing Information. Tarsus Pharmaceuticals Inc; 2023. 5. XDEMVY Pivotal Trial Data Presentation. Tarsus Pharmaceuticals Inc.

References: 1. Fromstein SR, Harthan JS, Patel J, Opitz DL. Demodex blepharitis: clinical perspectives. Clin Optom (Auckl). 2018;10:57-63. 2. Trattler W, Karpecki P, Rapoport Y, et al. The prevalence of Demodex blepharitis in US eye care clinic patients as determined by collarettes: a pathognomonic sign. Clin Ophthalmol. 2022;16:1153-1164. 3. Sędzikowska A, Osęka M, Grytner-Zięcina B. Ocular symptoms reported by patients infested with Demodex mites. Acta Parasitol. 2016;61(4):808-814. 4. XDEMVY. Prescribing Information. Tarsus Pharmaceuticals Inc; 2023. 5. XDEMVY Pivotal Trial Data Presentation. Tarsus Pharmaceuticals Inc.

Footer address

15440 Laguna Canyon Road, Ste 160
Irvine, CA 92618

©2025 Tarsus Pharmaceuticals, Inc.  
Tarsus, the Tarsus logo, XDEMVY, the XDEMVY logo, and certain other trademarks herein are trademarks of Tarsus Pharmaceuticals, Inc.   
US--2500012 3/25

You are leaving the XDEMVY® patient website and going to the Tarsus Pharmaceuticals, Inc. corporate website.

You are leaving the XDEMVY® patient website and going to the healthcare professional website.

You are leaving the XDEMVY® patient website.

Are you a US healthcare professional?

Click YES to leave this site, or click NO to return to the XDEMVY patient site.

YES NO

Concierge

Indications and Usage

XDEMVY (lotilaner ophthalmic solution) 0.25% is indicated for the treatment of Demodex blepharitis.

Important Safety Information

Most common side effects: The most common side effect in clinical trials was stinging and burning in 10% of patients. Other side effects in less than 2% of patients were chalazion/hordeolum and punctate keratitis. 

Handling the Container: Avoid allowing the tip of the dispensing container to contact the eye, surrounding structures, fingers, or any other surface in order to minimize contamination of the solution. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions.

When to Seek Physician Advice: Immediately seek a physician’s advice concerning the continued use of XDEMVY if you develop an intercurrent ocular condition (e.g., trauma or infection), have ocular surgery, or develop any ocular reactions, particularly conjunctivitis and eyelid reactions. 

Use with Contact Lenses: XDEMVY contains potassium sorbate, which may discolor soft contact lenses. Contact lenses should be removed prior to instillation of XDEMVY and may be reinserted 15 minutes following its administration.

To report SUSPECTED ADVERSE REACTIONS, contact Tarsus Pharmaceuticals at 1-888-421-4002 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Please see full Prescribing Information.

By prescription only.